It is a pharma private limited company based in Arjun Nagar, Haryana, India, established in 2023.
2023 | Arjun Nagar, Haryana, India | ActiveSuper Nova Life Drugs Private Limited, a active private limited company, was established on 16 May 2023 in Arjun Nagar, Haryana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U21002HR2023PTC111699. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.92 Cr.
Its leadership includes Alka Lakhani (Director), Pradeep Kumar Sharma (Individual Subscriber), Ramji Lal (Director). Past directors included Pradeep Kumar Sharma, Reshmi Devi, Hrishabh Vasishtha. It holds ₹12.15 Cr open charges and no settled loans. Its latest AGM occurred on 11 November 2024, with the balance sheet filed on 31 March 2024. It is based at Sts 331, Dlf Star Tower,, Sector-30, Silokhera,, Arjun Nagar, Haryana, 122001.
U21002HR2023PTC111699
111699
16 May 2023
₹2.00 Cr
₹1.92 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Super Nova Life Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alka Lakhani | Director | 16 May 2023 | Current |
| Pradeep Kumar Sharma | Individual Subscriber | 16 May 2023 | Current |
| Ramji Lal | Director | 16 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 Nov 2024 | Past |
| Pramod Abcsdd | Individual Subscriber | - | Past |
| Pramod Abcsdd | Individual Subscriber | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Super Nova Life Drugs Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Super Nova Life Drugs had a public holding of 7.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹121,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2024 | Others | ₹2.15 Cr | Open |
| 06 Nov 2023 | Others | ₹7.50 Cr | Open |
| 06 Nov 2023 | Others | ₹2.50 Cr | Open |
Explore comprehensive loan charge details -
Super Nova Life Drugs has a workforce of 0 employees as of Mar 01, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Super Nova Life Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Super Nova Life Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Super Nova Life Drugs Private Limited last Annual general meeting of members was held on 11 Nov 2024 as per latest MCA records. was recorded as a recent event.
Progress on Super Nova Life Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Others amounted to Rs. 2.15 Cr with Charge ID 100898689 was registered on 22 Mar 2024. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100820408 was registered on 06 Nov 2023. was documented.
Progress on A charge with Others amounted to Rs. 2.50 Cr with Charge ID 100820386 was registered on 06 Nov 2023. was documented.
The activity Alka Lakhani was appointed as a Director was appointed as a Director on 16 May 2023 & has been associated with this company since 2 years 6 months . was completed.
The CIN of Super Nova Life Drugs Private Limited is U21002HR2023PTC111699.
Super Nova Life Drugs Private Limited is headquartered at Sts 331, Dlf Star Tower,, Sector-30, Silokhera,, Arjun Nagar, Haryana, 122001.
Super Nova Life Drugs Private Limited was incorporated on 16 May 2023.
The current directors of Super Nova Life Drugs Private Limited are
The primary industry of Super Nova Life Drugs Private Limited is Pharma.
Super Nova Life Drugs Private Limited is unlisted.
The authorized capital of Super Nova Life Drugs Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.92 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX